Product correctly added to cart.

discount label
Octahydro-1H-isoindol-1-one
View 3D

Biosynth logo

Octahydro-1H-isoindol-1-one

CAS: 2555-11-5

Ref. 3D-CAA55511

5mg
215.00 €
50mg
856.00 €
Estimated delivery in United States, on Friday 29 Nov 2024

Product Information

Name:
Octahydro-1H-isoindol-1-one
Synonyms:
  • 8-Azabicyclo[4.3.0]nonan-7-one
  • Octahydro-1H-isoindol-1-one
  • Phthalimidine,hexahydro- (6CI,7CI,8CI)
  • NSC 338089
Description:

Octahydro-1H-isoindol-1-one is an isomeric compound that has been shown to inhibit the α2δ subunit of voltage-gated calcium channels. It has a high affinity for the carboxylate site on the α2δ subunit, and it inhibits the excretory function of detrusor muscle, which can lead to urinary retention. The b2 receptor is a G protein coupled receptor that is activated by bradykinin and regulates the activity of excitable cells. Octahydro-1H-isoindol-1-one binds to the b2 receptor, blocking its activation by bradykinin, which leads to vasodilation and inhibition of platelet aggregation. This agent also acts as an antiplatelet agent and as an adrenergic antagonist.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
139.19 g/mol
Formula:
C8H13NO
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-CAA55511 Octahydro-1H-isoindol-1-one

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".